These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11421561)

  • 1. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms.
    Bidot P; Morgan M; Zhukov T; Tannenbaum M; Tockman MS
    Endocr Pract; 2001; 7(3):157-61. PubMed ID: 11421561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA; Bashandy MA; Abdou AG; Zahran AA
    Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG1 protein overexpression in malignant thyroid neoplasms.
    Gerhard R; Nonogaki S; Fregnani JH; Soares FA; Nagai MA
    Clinics (Sao Paulo); 2010 Jun; 65(8):757-62. PubMed ID: 20835551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.
    Kim JY; Cho H; Rhee BD; Kim HY
    Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
    Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
    Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of BRAF V600E mutation in different thyroid lesions].
    Wang W; Li XH; Zhang YH; Li J; Chen J; Zhao P; Li QY; Xiang JJ; Li X; Xu RJ
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):354-7. PubMed ID: 21875464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
    Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
    Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Met expression of thyroid tissue with special reference to papillary carcinoma.
    Oyama T; Ichimura E; Sano T; Kashiwabara K; Fukuda T; Nakajima T
    Pathol Int; 1998 Oct; 48(10):763-8. PubMed ID: 9788259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
    Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
    Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
    Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
    Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
    Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.